Answers are grounded in this paper and cite their sources.
Case report describes acute ischemic stroke in a young woman with thiamine-responsive megaloblastic anemia syndrome, highlighting rare vascular complications.
We report the case of a 20-yr-old girl with thiamine-responsive megaloblastic anemia (TRMA) associated with diabetes mellitus and bilateral sensorineural deafness (1, 2). Megaloblastic anemia was diagnosed at 7 months and was successfully treated with multiple vitamin preparations. Diabetes was diagnosed at age 2 yr and was treated with insulin for 6 months at a dose of 0.5 IU/kg BW. The diagnosis of TRMA syndrome was clinically confirmed when bilateral sensorineural deafness was detected. Thereafter, thiamine treatment was started (50 mg/day), and insulin was discontinued because of frequent episodes of hypoglycemia. At age 9 yr, due to reoccurrence of hyperglycemia, the patient underwent glibenclamide treatment (2.5 mg/day), which was replaced by insulin at menarche. Glycemic control was satisfactory, as evidenced by hemoglobin A1c (HbA1c) values between 7.5–8%. Laboratory parameters, including coagulation factors, were in the normal range. At age 17 yr, because of secondary amenorrhea and echographic findings of small ovarian cysts, the patient was diagnosed as having polycystic ovary syndrome and was treated with estro-progestins (12 cycles/yr of ciproterone, ethinyl estradiol). One year later, at age 18 yr, the patient developed motor seizures initially involving the left leg, then rapidly extending to the whole body, followed by unconsciousness. On admission, left hemiplegia was observed. Arterial blood pressure and plasma lipid concentrations were normal (100/60 mm Hg; total cholesterol, 147 mg/dL; total triglycerides, 84 mg/dL). The patient was receiving insulin therapy (30–35 IU/24 h), and the average HbA1c levels had been between 7.1–7.3% during the previous year. A computed tomography scanning revealed a small area of edema at the right cerebral hemisphere; 24 h later an ischemic area involving the territory of the right middle cerebral artery became manifest. One month later, during antiepileptic and ticlopidine therapy, the patient developed clonic movements of the left leg followed by generalized coreic movements and unconsciousness. Brain magnetic resonance (MR) imaging and angiography showed severely reduced blood flow in the right middle cerebral artery, with a large ischemic area in the corresponding territory, absence of flow in the distal internal carotid arteries, and slight compensatory hypertrophy of the basilar artery (Fig. 1). X-Ray digital arteriography confirmed MR findings and showed narrowing of the left superficial femoral and popliteas arteries. Hemostasis tests revealed high fibrinogen levels (612 mg/dL), whereas prothrombin, APTT, antithrombin III, and protein S were normal. Anticardiolipin (IgG and IgM) and lupus anticoagulant antibodies were also normal. In contrast, a low activity of protein C (60% vs. 98 6 15%) was found, which reverted to normal after a year. Further investigation for a hypercoagulable state showed negative factor V Leiden and a homocysteine concentration in the normal range. In addition, screening for prothrombin gene G20210A mutation and mutations of two enzymes involved in homocysteine metabolism, i.e. C677T in the coding region for N,N-methylenetetrahydrofolate reductase and cystathionine b-synthase 844INS68, gave negative results. On hospital discharge, the patient had left-sided hemiparesis. Oral anticoagulant and antiepileptic drugs were prescribed together with insulin and thiamine, which induced satisfactory glycemic control and resumption of menses. During the 1-yr follow-up the patient progressively recovered upper limb motility and is now independent with regard to everyday life needs.
No takes yet. Share an insight, caveat, or question.
Villa et al. (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: